title: What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.
authors.affiliation: Clinical Microbiology and Virology Unit, Department of Transfusion Medicine, Spirito Santo Hospital, Pescara, Italy. vincsavi@yahoo.it
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Savini
authors.forename: Chiara
authors.initials: C
authors.lastname: Catavitello
authors.forename: Daniela
authors.initials: D
authors.lastname: Onofrillo
authors.forename: Gioviana
authors.initials: G
authors.lastname: Masciarelli
authors.forename: Daniela
authors.initials: D
authors.lastname: Astolfi
authors.forename: Andrea
authors.initials: A
authors.lastname: Balbinot
authors.forename: Fabio
authors.initials: F
authors.lastname: Febbo
authors.forename: Claudio
authors.initials: C
authors.lastname: D'Amario
authors.forename: Domenico
authors.initials: D
authors.lastname: D'Antonio
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use; D002175:Candida / Q000145:classification / Q000302:isolation & purification*; D002177:Candidiasis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D021821:Communicable Diseases, Emerging / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D025141:Drug Resistance, Fungal; D006801:Humans; D016867:Immunocompromised Host; D008826:Microbial Sensitivity Tests; D017211:Treatment Failure
chemical_list: D000935:Antifungal Agents